ImmunoGenesis
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab (NCT06782555) | ImmunoGenesis | 2025-01-08 |
| Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors (NCT06014502) | ImmunoGenesis | 2023-09-07 |
Track ImmunoGenesis automatically
Every clearance here is in the API, with alerts when new ones post.